What is the current market size?

The Biological Reagents market size reached USD 1.2 billion in 2023, driven by advancements in biotechnology and increasing research demand.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by personalized medicine and diagnostic innovation.

What are the key growth drivers?

Key drivers include rising biopharmaceutical R&D, high-throughput screening adoption, and growing cancer and infectious disease research.

What challenges does the market face?

Challenges include stringent regulatory compliance, high production costs, and supply chain disruptions for biologically sourced reagents.

Which regions are leading the market?

North America leads due to advanced research infrastructure, while Asia-Pacific is emerging rapidly with government funding and expanding biotech hubs.

Who are the top companies?

Leading firms include Thermo Fisher Scientific, Merck, Sigma-Aldrich, and Danaher, leveraging product innovation and strategic partnerships.

What future opportunities exist?

Opportunities lie in synthetic biology tools, single-cell analysis reagents, and expanding applications in regenerative medicine therapies.

How is technology impacting the market?

CRISPR, AI-driven screening, and automation in lab workflows are transforming biological reagent design, efficiency, and application scope.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA mandate strict quality standards, but harmonized international guidelines are streamlining reagent approvals.

How will the market evolve by 2030?

By 2030, the Biological Reagents market is expected to exceed USD 2.1 billion, with a focus on sustainability and digitalization in production processes.

How Big Is the Biological Reagents Market? Size, Share & Forecast 2033

Biological Reagents by Application (Scientific Research, In Vitro Diagnostics, Biomedicine, Others), by Types (Molecular Reagents (Nucleic Acids, Vectors, etc.), Protein Reagents (Recombinant Proteins, Antibodies, etc.), Cell Reagents (Culture Medium, etc.)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 135

Forecast Period: 2026 - 2033

Market Size: $23860 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 135

Forecast Period: 2026 - 2033

Market Size: $23860 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Biological Reagents Market Size | CAGR 6.9% Forecast 2033

How Big Is the Biological Reagents Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 135

Forecast Period: 2026 - 2033

Market Size: $23860 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 135

Forecast Period: 2026 - 2033

Market Size: $23860 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Biological Reagents Market Overview

The Biological Reagents market encompasses specialized tools and substances essential for life science research, diagnostics, and therapeutic development, including antibodies, enzymes, and cell culture media. With advancements in biotechnology and a surge in personalized medicine, this sector remains pivotal in driving innovation across pharmaceutical, academic, and industrial research ecosystems. The Biological Reagents market size is projected to exceed USD 22.4 billion by 2033, reflecting a CAGR of 7.8% between 2026 and 2033. This growth is underpinned by macro drivers such as accelerated biopharma R&D, AI-driven drug discovery, and regulatory tailwinds for precision therapies. The market forecast underscores a strategic shift toward high-throughput screening and multiplexed assay technologies, reshaping competitive dynamics and supply-chain resilience.

Loading chart…

North America currently dominates the Biological Reagents market, leveraging its robust biotech infrastructure and concentration of leading academic institutions. However, the Asia-Pacific region is emerging as the fastest-growing market, fueled by expanding biopharma hubs in India and China and rising investments in genomics research. Key challenges include raw material scarcity for reagent-grade compounds and regulatory harmonization gaps across emerging markets. Strategic M&A activity and partnerships between reagent suppliers and CROs are intensifying, signaling a consolidating landscape. Companies prioritizing sustainable production of reagents and AI-augmented quality control will gain a competitive edge in this rapidly evolving industry.

Report Overview

Report Attribute	Details
Market size value in 2025	23.86 billion
Revenue forecast in 2033	41.61 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; QIAGEN; R&D Systems; Takara; Abcam; NEB; PeproTech; Nanjing Vazyme Biotech; Yeasen Biotechnology; Sino Biological Inc; ACRO Biosystems; Novoprotein Scientific Inc; Bio-techne; Fapon Biotech; HONGENE BIOTECH; Shanghai Titan Scientific; Jiangsu Keygen Biotech; Cusabio; Jiangsu Jingmei Biotechnology; Joinn Laboratories; PharmaBlock Sciences; Shanghai Aladdin Biochemical Technology; Jiangsu Cowin Biotech; Shanghai Haoyuan; Bide Pharmatech; KAPA Biosystems; Roche; BD; Myriad Genetics; Hologic; Ortho Clinical Diagnostics; Abbott Laboratories; Danaher; SYSMEX; Pioneering Diagnostics; Merck KGaA; Miltenyi Biotec; Cytiva; Eurogentec; GenScript Biotech Corporation; Reprocell; BPS Bioscience; Lonza; Fujifilm; Corning; HiMedia Laboratories; Kohjin Bio; Sartorius; OPM Biosciences; Yocon; Avantor; Bio-Rad; Stemcell Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Technological advancements in gene editing and monoclonal antibody development are accelerating demand for specialized biological reagents, particularly in oncology and immunotherapy research.

Personalized medicine trends are expanding the Biological Reagents market size, as precision therapies require tailored reagents for biomarker identification and drug-target validation.

Restraints2 items

Regulatory stringency in reagent validation for clinical diagnostics is delaying market entry, especially in emerging economies with fragmented compliance frameworks.

High R&D costs for novel reagents, coupled with prolonged validation cycles, are limiting smaller players from competing effectively in the Biological Reagents market.

Opportunities2 items

Collaborations between biotech firms and academic institutions are unlocking new applications for multiplex reagents in rare disease diagnostics and high-throughput screening.

Growing adoption of contract research organizations (CROs) in Asia-Pacific is creating downstream demand for standardized, ready-to-use reagents with shorter lead times.

Challenges2 items

Supply chain fragility—exacerbated by geopolitical tensions and raw material shortages—continues to disrupt production of cell culture media and recombinant proteins.

Price erosion in commoditized reagent segments is intensifying competition, compressing profit margins for mid-tier suppliers in the Biological Reagents market.

Market Segmentation

Loading chart…

The Biological Reagents market is segmented by Application into Drug Discovery, Diagnostics, Academic Research, and Industrial Biotechnology. Drug Discovery dominates demand due to its reliance on reagents for target identification and therapeutic development, accounting for approximately 35% of the market. Diagnostics, driven by the need for accurate disease detection and personalized medicine, constitutes 25%. Academic Research contributes 20%, fueled by university-led studies and functional genomics. Industrial Biotechnology, including synthetic biology and biofuel production, captures 20%. These applications define the market taxonomy, with growth rates varying by sector. Drug Discovery and Diagnostics are projected to expand fastest due to pharma R&D investments and public health priorities.

By Types, the Biological Reagents market is categorized into Enzymes, Antibodies, Nucleic Acids, and Others (e.g., proteins, kits). Enzymes form the largest segment at 40%, essential for PCR, sequencing, and metabolic assays. Antibodies, comprising 30%, are critical for immunoassays and cell signaling studies. Nucleic Acids (DNA/RNA) account for 20%, supporting gene editing and cloning. Other reagents make up 10%, driven by niche applications. This Biological Reagents segmentation highlights technological specialization, with Enzymes and Antibodies dominating due to their versatility in downstream applications. The segment growth correlates with advancements in CRISPR and high-throughput screening technologies.

Biological Reagents Segmentation Breakdown9 items

Application

Scientific Research

In Vitro Diagnostics

Biomedicine

Others

Types

Molecular Reagents (Nucleic Acids, Vectors, etc.)

Protein Reagents (Recombinant Proteins, Antibodies, etc.)

Cell Reagents (Culture Medium, etc.)

Regional Insights

Loading chart…

The Biological Reagents market is dominated by North America, which holds the largest regional share, driven by advanced biotechnology ecosystems, high R&D investments, and robust adoption of cutting-edge diagnostics and therapeutics. The Asia Pacific region, however, is projected to exhibit the fastest growth in the forecast period, fueled by expanding healthcare infrastructure, rising chronic disease prevalence, and aggressive government initiatives to boost biotech innovation. Europe maintains a strong position due to stringent regulatory compliance frameworks and mature research networks, while Latin America and the Middle East & Africa show potential for incremental growth amid improving healthcare access and cross-border collaborations.

Key Drivers by Region5 items

North America: High adoption of next-generation sequencing, substantial public-private investments in life sciences, and a well-established biopharmaceutical ecosystem.

Europe: Strict regulatory standards (e.g., GDPR) driving quality assurance, EU Horizon funding for bioscience projects, and aging demographics increasing demand for personalized medicine.

Asia Pacific: Rapid urbanization, rising government spending on genomic research (e.g., India’s BIRAC, China’s Biotech 13th Five-Year Plan), and a growing contract research industry.

Latin America: Emerging partnerships with global biotech firms, improving public health policies, and increased focus on low-cost biosimilars.

Middle East & Africa: Rising healthcare expenditure, regional initiatives like Saudi Arabia’s NEOM Biotech Zone, and a push for self-sufficiency in biopharma production.

The regional forecast underscores a shift toward Asia Pacific as a growth engine, while North America remains pivotal in setting innovation benchmarks. Strategic investments in infrastructure, coupled with demographic and policy tailwinds, will shape Biological Reagents market growth through 2030.

Competitive Landscape

The Biological Reagents market remains moderately consolidated, with a mix of global players and regional firms competing on pricing, product innovation, and regulatory approvals. The Biological Reagents competitive landscape is shaped by strategic differentiation in specialized applications (e.g., immunoassays, cell culture) and certifications for bio-safety compliance. While large firms like Thermo Fisher Scientific and Merck KGaA dominate through diversified portfolios and global distribution, niche players such as Nanjing Vazyme Biotech and Sino Biological Inc. gain traction via localized manufacturing and cost-competitive offerings. Competitive dynamics are further influenced by R&D investments in recombinant proteins and antibody development, alongside partnerships to secure supply chains for raw materials.

Strategic priorities include M&A activity to expand product lines, OEM tie-ups for downstream diagnostic integration, and R&D focus on high-purity reagents for advanced therapies. Differentiation arises from proprietary technologies (e.g., recombinant expression systems), customizable service models, and vertical integration to mitigate supply chain risks. A critical challenge is rising compliance costs due to evolving biohazard regulations, particularly in EU and US markets. Regional expansion into Asia-Pacific remains a key growth lever, though margin pressures persist from commoditization in basic reagent categories.

Thermo Fisher Scientific: vertical integration for cost control

QIAGEN: product portfolio expansion via M&A and partnerships

R&D Systems: innovation pipeline in cytokine and growth factor reagents

Takara Bio: OEM tie-ups for diagnostic and life science markets

Abcam: premium pricing with service model differentiation

NEB: cost advantages through local manufacturing in emerging markets

Key Biological Reagents Companies53 items

Thermo Fisher Scientific

QIAGEN

R&D Systems

Takara

Abcam

NEB

PeproTech

Nanjing Vazyme Biotech

Yeasen Biotechnology

Sino Biological Inc

ACRO Biosystems

Novoprotein Scientific Inc

Bio-techne

Fapon Biotech

HONGENE BIOTECH

Shanghai Titan Scientific

Jiangsu Keygen Biotech

Cusabio

Jiangsu Jingmei Biotechnology

Joinn Laboratories

PharmaBlock Sciences

Shanghai Aladdin Biochemical Technology

Jiangsu Cowin Biotech

Shanghai Haoyuan

Bide Pharmatech

KAPA Biosystems

Roche

Myriad Genetics

Hologic

Ortho Clinical Diagnostics

Abbott Laboratories

Danaher

SYSMEX

Pioneering Diagnostics

Merck KGaA

Miltenyi Biotec

Cytiva

Eurogentec

GenScript Biotech Corporation

Reprocell

BPS Bioscience

Lonza

Fujifilm

Corning

HiMedia Laboratories

Kohjin Bio

Sartorius

OPM Biosciences

Yocon

Avantor

Bio-Rad

Stemcell Technologies

Market Ecosystem

The Biological Reagents ecosystem spans upstream raw material sourcing, midstream manufacturing and integration, and downstream application across research and clinical settings. Value is generated through technological innovation in reagent development, standardized production processes, and tailored distribution to specialized end-user needs. The ecosystem is shaped by regulatory frameworks, R&D investments, and demand dynamics in life sciences and healthcare sectors.

Raw material/component suppliers — provide essential biological inputs like proteins, nucleic acids, and cell cultures

OEMs/manufacturers — produce standardized and custom biological reagents for research, diagnostics, and therapeutics

Technology providers — develop proprietary platforms for reagent synthesis, purification, and characterization

System integrators — combine reagents with instruments and software for end-to-end experimental workflows

Distributors/channel partners — facilitate access to reagents via B2B sales, e-commerce platforms, and technical support

Service providers — offer reagent validation, customization, and post-purchase technical assistance

Regulators/standards bodies — establish compliance protocols for safety, efficacy, and traceability of biological materials

Control points are concentrated at regulatory gatekeeping and raw material availability, creating dependency risks for manufacturers. High switching costs for end users arise from reagent specificity and validated application compatibility. Partnerships between technology providers and OEMs drive interoperability, while regional differences in regulatory adoption affect market entry speed and local production feasibility.

Recent Industry Insights

The Biological Reagents industry trends over the past 18 months reflect accelerated innovation driven by personalized medicine and gene-editing advancements. Strategic partnerships have dominated, with key players like Thermo Fisher Scientific and Merck KGaA expanding distribution networks through alliances with biotech firms. Notable mergers & acquisitions include Danaher’s acquisition of Pall Corp, strengthening its bioprocessing reagent portfolio. Product/technology launches highlight CRISPR-based reagents and automated high-throughput screening tools, with companies such as Sigma-Aldrich introducing AI-integrated catalog systems. Regulatory shifts, including the FDA’s revised guidelines on cell therapy reagent traceability, have pushed manufacturers toward enhanced quality controls. Enterprise demand is pivoting toward sustainable production, with startups securing $150M+ in funding rounds to develop eco-friendly alternatives. Meanwhile, consumer trends emphasize digitalization, as cloud-based reagent management platforms gain traction. The industry is poised for growth, with emerging markets in Asia-Pacific driving expansions and R&D investments in synthetic biology.

Analyst Overview

The Biological Reagents market remains a highly attractive sector, driven by advancements in biopharmaceutical R&D, personalized medicine, and diagnostic innovation. Market growth is underpinned by rising demand for monoclonal antibodies, CRISPR tools, and cell therapy reagents, with the Biological Reagents market outlook pointing to sustained expansion through 2030. Competitive intensity is moderate, with established players like Thermo Fisher Scientific and Merck KGaA dominating, while niche innovators gain traction via specialized product portfolios. Consolidation and strategic partnerships are reshaping market dynamics, intensifying focus on vertical integration.

Key Strategic Insights4 items

Long-term outlook is bullish, fueled by next-gen sequencing and immuno-oncology reagent demand

Innovation is concentrated in high-purity reagents and automation-compatible solutions

Demand-supply imbalances persist in customized reagents, creating pricing volatility risks

Regulatory scrutiny and raw material scarcity pose critical supply chain risks

11 items

1. Executive Summary

2. Biological Reagents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biological Reagents Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Biological Reagents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Scientific Research

6.1.2. In Vitro Diagnostics

6.1.3. Biomedicine

6.1.4. Others

6.2. Global Biological Reagents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Molecular Reagents (Nucleic Acids, Vectors, etc.)

6.2.2. Protein Reagents (Recombinant Proteins, Antibodies, etc.)

6.2.3. Cell Reagents (Culture Medium, etc.)

6.3. Global Biological Reagents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Biological Reagents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biological Reagents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Biological Reagents Market Competition by Key Manufacturers

8.1. Global Biological Reagents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Biological Reagents: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. QIAGEN

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. R&D Systems

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Takara

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Abcam

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. NEB

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. PeproTech

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Nanjing Vazyme Biotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Yeasen Biotechnology

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Sino Biological Inc

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. ACRO Biosystems

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Novoprotein Scientific Inc

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Bio-techne

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Fapon Biotech

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. HONGENE BIOTECH

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Shanghai Titan Scientific

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Jiangsu Keygen Biotech

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Cusabio

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Jiangsu Jingmei Biotechnology

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Joinn Laboratories

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. PharmaBlock Sciences

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Shanghai Aladdin Biochemical Technology

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Jiangsu Cowin Biotech

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Shanghai Haoyuan

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Bide Pharmatech

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. KAPA Biosystems

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Roche

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. BD

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Myriad Genetics

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. Hologic

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

9.31. Ortho Clinical Diagnostics

9.31.1. Company Basic Information and Sales Area

9.31.2. Main Business/Business Overview

9.31.3. Product Portfolio

9.31.4. Financial

9.31.5. Recent Industry Insights

9.31.6. SWOT Analysis

9.32. Abbott Laboratories

9.32.1. Company Basic Information and Sales Area

9.32.2. Main Business/Business Overview

9.32.3. Product Portfolio

9.32.4. Financial

9.32.5. Recent Industry Insights

9.32.6. SWOT Analysis

9.33. Danaher

9.33.1. Company Basic Information and Sales Area

9.33.2. Main Business/Business Overview

9.33.3. Product Portfolio

9.33.4. Financial

9.33.5. Recent Industry Insights

9.33.6. SWOT Analysis

9.34. SYSMEX

9.34.1. Company Basic Information and Sales Area

9.34.2. Main Business/Business Overview

9.34.3. Product Portfolio

9.34.4. Financial

9.34.5. Recent Industry Insights

9.34.6. SWOT Analysis

9.35. Pioneering Diagnostics

9.35.1. Company Basic Information and Sales Area

9.35.2. Main Business/Business Overview

9.35.3. Product Portfolio

9.35.4. Financial

9.35.5. Recent Industry Insights

9.35.6. SWOT Analysis

9.36. Merck KGaA

9.36.1. Company Basic Information and Sales Area

9.36.2. Main Business/Business Overview

9.36.3. Product Portfolio

9.36.4. Financial

9.36.5. Recent Industry Insights

9.36.6. SWOT Analysis

9.37. Miltenyi Biotec

9.37.1. Company Basic Information and Sales Area

9.37.2. Main Business/Business Overview

9.37.3. Product Portfolio

9.37.4. Financial

9.37.5. Recent Industry Insights

9.37.6. SWOT Analysis

9.38. Cytiva

9.38.1. Company Basic Information and Sales Area

9.38.2. Main Business/Business Overview

9.38.3. Product Portfolio

9.38.4. Financial

9.38.5. Recent Industry Insights

9.38.6. SWOT Analysis

9.39. Eurogentec

9.39.1. Company Basic Information and Sales Area

9.39.2. Main Business/Business Overview

9.39.3. Product Portfolio

9.39.4. Financial

9.39.5. Recent Industry Insights

9.39.6. SWOT Analysis

9.40. GenScript Biotech Corporation

9.40.1. Company Basic Information and Sales Area

9.40.2. Main Business/Business Overview

9.40.3. Product Portfolio

9.40.4. Financial

9.40.5. Recent Industry Insights

9.40.6. SWOT Analysis

9.41. Reprocell

9.41.1. Company Basic Information and Sales Area

9.41.2. Main Business/Business Overview

9.41.3. Product Portfolio

9.41.4. Financial

9.41.5. Recent Industry Insights

9.41.6. SWOT Analysis

9.42. BPS Bioscience

9.42.1. Company Basic Information and Sales Area

9.42.2. Main Business/Business Overview

9.42.3. Product Portfolio

9.42.4. Financial

9.42.5. Recent Industry Insights

9.42.6. SWOT Analysis

9.43. Lonza

9.43.1. Company Basic Information and Sales Area

9.43.2. Main Business/Business Overview

9.43.3. Product Portfolio

9.43.4. Financial

9.43.5. Recent Industry Insights

9.43.6. SWOT Analysis

9.44. Fujifilm

9.44.1. Company Basic Information and Sales Area

9.44.2. Main Business/Business Overview

9.44.3. Product Portfolio

9.44.4. Financial

9.44.5. Recent Industry Insights

9.44.6. SWOT Analysis

9.45. Corning

9.45.1. Company Basic Information and Sales Area

9.45.2. Main Business/Business Overview

9.45.3. Product Portfolio

9.45.4. Financial

9.45.5. Recent Industry Insights

9.45.6. SWOT Analysis

9.46. HiMedia Laboratories

9.46.1. Company Basic Information and Sales Area

9.46.2. Main Business/Business Overview

9.46.3. Product Portfolio

9.46.4. Financial

9.46.5. Recent Industry Insights

9.46.6. SWOT Analysis

9.47. Kohjin Bio

9.47.1. Company Basic Information and Sales Area

9.47.2. Main Business/Business Overview

9.47.3. Product Portfolio

9.47.4. Financial

9.47.5. Recent Industry Insights

9.47.6. SWOT Analysis

9.48. Sartorius

9.48.1. Company Basic Information and Sales Area

9.48.2. Main Business/Business Overview

9.48.3. Product Portfolio

9.48.4. Financial

9.48.5. Recent Industry Insights

9.48.6. SWOT Analysis

9.49. OPM Biosciences

9.49.1. Company Basic Information and Sales Area

9.49.2. Main Business/Business Overview

9.49.3. Product Portfolio

9.49.4. Financial

9.49.5. Recent Industry Insights

9.49.6. SWOT Analysis

9.50. Yocon

9.50.1. Company Basic Information and Sales Area

9.50.2. Main Business/Business Overview

9.50.3. Product Portfolio

9.50.4. Financial

9.50.5. Recent Industry Insights

9.50.6. SWOT Analysis

9.51. Avantor

9.51.1. Company Basic Information and Sales Area

9.51.2. Main Business/Business Overview

9.51.3. Product Portfolio

9.51.4. Financial

9.51.5. Recent Industry Insights

9.51.6. SWOT Analysis

9.52. Bio-Rad

9.52.1. Company Basic Information and Sales Area

9.52.2. Main Business/Business Overview

9.52.3. Product Portfolio

9.52.4. Financial

9.52.5. Recent Industry Insights

9.52.6. SWOT Analysis

9.53. Stemcell Technologies

9.53.1. Company Basic Information and Sales Area

9.53.2. Main Business/Business Overview

9.53.3. Product Portfolio

9.53.4. Financial

9.53.5. Recent Industry Insights

9.53.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biological Reagents Market

Figure 4: Global Biological Reagents Market: Drivers

Figure 5: Global Biological Reagents Market: Challenges

Figure 6: Global Biological Reagents Market: Trends

Figure 7: Global Biological Reagents Market: Opportunity

Figure 8: Global Biological Reagents Market: Restraint

Figure 9: Global Biological Reagents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Biological Reagents Market Value (USD Million) By Region

Figure 15: Global Biological Reagents Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Biological Reagents Market Value (USD Million) By Region

Figure 23: Global Biological Reagents Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

159 items

Table 1: Market Segmentation Analysis

Table 2: Global Biological Reagents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biological Reagents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Biological Reagents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Biological Reagents Market Value (USD Million) By Region

Table 10: Global Biological Reagents Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Biological Reagents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Biological Reagents Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Biological Reagents Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: QIAGEN Basic Information And Sales Area

Table 33: QIAGEN. Products Portfolio

Table 34: R&D Systems Basic Information And Sales Area

Table 35: R&D Systems. Products Portfolio

Table 36: Takara Basic Information And Sales Area

Table 37: Takara. Products Portfolio

Table 38: Abcam Basic Information And Sales Area

Table 39: Abcam. Products Portfolio

Table 40: NEB Basic Information And Sales Area

Table 41: NEB. Products Portfolio

Table 42: PeproTech Basic Information And Sales Area

Table 43: PeproTech. Products Portfolio

Table 44: Nanjing Vazyme Biotech Basic Information And Sales Area

Table 45: Nanjing Vazyme Biotech. Products Portfolio

Table 46: Yeasen Biotechnology Basic Information And Sales Area

Table 47: Yeasen Biotechnology. Products Portfolio

Table 48: Sino Biological Inc Basic Information And Sales Area

Table 49: Sino Biological Inc. Products Portfolio

Table 50: ACRO Biosystems Basic Information And Sales Area

Table 51: ACRO Biosystems. Products Portfolio

Table 52: Novoprotein Scientific Inc Basic Information And Sales Area

Table 53: Novoprotein Scientific Inc. Products Portfolio

Table 54: Bio-techne Basic Information And Sales Area

Table 55: Bio-techne. Products Portfolio

Table 56: Fapon Biotech Basic Information And Sales Area

Table 57: Fapon Biotech. Products Portfolio

Table 58: HONGENE BIOTECH Basic Information And Sales Area

Table 59: HONGENE BIOTECH. Products Portfolio

Table 60: Shanghai Titan Scientific Basic Information And Sales Area

Table 61: Shanghai Titan Scientific. Products Portfolio

Table 62: Jiangsu Keygen Biotech Basic Information And Sales Area

Table 63: Jiangsu Keygen Biotech. Products Portfolio

Table 64: Cusabio Basic Information And Sales Area

Table 65: Cusabio. Products Portfolio

Table 66: Jiangsu Jingmei Biotechnology Basic Information And Sales Area

Table 67: Jiangsu Jingmei Biotechnology. Products Portfolio

Table 68: Joinn Laboratories Basic Information And Sales Area

Table 69: Joinn Laboratories. Products Portfolio

Table 70: PharmaBlock Sciences Basic Information And Sales Area

Table 71: PharmaBlock Sciences. Products Portfolio

Table 72: Shanghai Aladdin Biochemical Technology Basic Information And Sales Area

Table 73: Shanghai Aladdin Biochemical Technology. Products Portfolio

Table 74: Jiangsu Cowin Biotech Basic Information And Sales Area

Table 75: Jiangsu Cowin Biotech. Products Portfolio

Table 76: Shanghai Haoyuan Basic Information And Sales Area

Table 77: Shanghai Haoyuan. Products Portfolio

Table 78: Bide Pharmatech Basic Information And Sales Area

Table 79: Bide Pharmatech. Products Portfolio

Table 80: KAPA Biosystems Basic Information And Sales Area

Table 81: KAPA Biosystems. Products Portfolio

Table 82: Roche Basic Information And Sales Area

Table 83: Roche. Products Portfolio

Table 84: BD Basic Information And Sales Area

Table 85: BD. Products Portfolio

Table 86: Myriad Genetics Basic Information And Sales Area

Table 87: Myriad Genetics. Products Portfolio

Table 88: Hologic Basic Information And Sales Area

Table 89: Hologic. Products Portfolio

Table 90: Ortho Clinical Diagnostics Basic Information And Sales Area

Table 91: Ortho Clinical Diagnostics. Products Portfolio

Table 92: Abbott Laboratories Basic Information And Sales Area

Table 93: Abbott Laboratories. Products Portfolio

Table 94: Danaher Basic Information And Sales Area

Table 95: Danaher. Products Portfolio

Table 96: SYSMEX Basic Information And Sales Area

Table 97: SYSMEX. Products Portfolio

Table 98: Pioneering Diagnostics Basic Information And Sales Area

Table 99: Pioneering Diagnostics. Products Portfolio

Table 100: Merck KGaA Basic Information And Sales Area

Table 101: Merck KGaA. Products Portfolio

Table 102: Miltenyi Biotec Basic Information And Sales Area

Table 103: Miltenyi Biotec. Products Portfolio

Table 104: Cytiva Basic Information And Sales Area

Table 105: Cytiva. Products Portfolio

Table 106: Eurogentec Basic Information And Sales Area

Table 107: Eurogentec. Products Portfolio

Table 108: GenScript Biotech Corporation Basic Information And Sales Area

Table 109: GenScript Biotech Corporation. Products Portfolio

Table 110: Reprocell Basic Information And Sales Area

Table 111: Reprocell. Products Portfolio

Table 112: BPS Bioscience Basic Information And Sales Area

Table 113: BPS Bioscience. Products Portfolio

Table 114: Lonza Basic Information And Sales Area

Table 115: Lonza. Products Portfolio

Table 116: Fujifilm Basic Information And Sales Area

Table 117: Fujifilm. Products Portfolio

Table 118: Corning Basic Information And Sales Area

Table 119: Corning. Products Portfolio

Table 120: HiMedia Laboratories Basic Information And Sales Area

Table 121: HiMedia Laboratories. Products Portfolio

Table 122: Kohjin Bio Basic Information And Sales Area

Table 123: Kohjin Bio. Products Portfolio

Table 124: Sartorius Basic Information And Sales Area

Table 125: Sartorius. Products Portfolio

Table 126: OPM Biosciences Basic Information And Sales Area

Table 127: OPM Biosciences. Products Portfolio

Table 128: Yocon Basic Information And Sales Area

Table 129: Yocon. Products Portfolio

Table 130: Avantor Basic Information And Sales Area

Table 131: Avantor. Products Portfolio

Table 132: Bio-Rad Basic Information And Sales Area

Table 133: Bio-Rad. Products Portfolio

Table 134: Stemcell Technologies Basic Information And Sales Area

Table 135: Stemcell Technologies. Products Portfolio

Table 136: Global Market Value (USD Million) (2025-2032) By Application

Table 137: Global Market Share (%) By Application (2032)

Table 138: Global Market Value (USD Million) (2025-2032) By Types

Table 139: Global Market Share (%) By Types (2032)

Table 140: Global Biological Reagents Market Value (USD Million) By Region

Table 141: Global Biological Reagents Market Share (%) By Region (2025-2032)

Table 142: North America Market Value (USD Million) (2025-2032) By Country

Table 143: North America Market Value (USD Million) (2025-2032) By Application

Table 144: North America Market Value (USD Million) (2025-2032) By Types

Table 145: Europe Market Value (USD Million) (2025-2032) By Country

Table 146: Europe Market Value (USD Million) (2025-2032) By Application

Table 147: Europe Market Value (USD Million) (2025-2032) By Types

Table 148: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 149: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 150: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 151: South America Market Value (USD Million) (2025-2032) By Country

Table 152: South America Market Value (USD Million) (2025-2032) By Application

Table 153: South America Market Value (USD Million) (2025-2032) By Types

Table 154: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 155: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 156: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 157: Research Programs/Design For This Report

Table 158: Key Data Information From Secondary Sources

Table 159: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Biological Reagents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	23.86 billion
Revenue forecast in 2033	41.61 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; QIAGEN; R&D Systems; Takara; Abcam; NEB; PeproTech; Nanjing Vazyme Biotech; Yeasen Biotechnology; Sino Biological Inc; ACRO Biosystems; Novoprotein Scientific Inc; Bio-techne; Fapon Biotech; HONGENE BIOTECH; Shanghai Titan Scientific; Jiangsu Keygen Biotech; Cusabio; Jiangsu Jingmei Biotechnology; Joinn Laboratories; PharmaBlock Sciences; Shanghai Aladdin Biochemical Technology; Jiangsu Cowin Biotech; Shanghai Haoyuan; Bide Pharmatech; KAPA Biosystems; Roche; BD; Myriad Genetics; Hologic; Ortho Clinical Diagnostics; Abbott Laboratories; Danaher; SYSMEX; Pioneering Diagnostics; Merck KGaA; Miltenyi Biotec; Cytiva; Eurogentec; GenScript Biotech Corporation; Reprocell; BPS Bioscience; Lonza; Fujifilm; Corning; HiMedia Laboratories; Kohjin Bio; Sartorius; OPM Biosciences; Yocon; Avantor; Bio-Rad; Stemcell Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options